Maciej Chyb

University Of Lodz Banacha 12/16 90-237 Lodz Poland
Lodz, LD 90237, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Discovery of novel anti-Toxoplasma gondii agent derived from thiazolidinone-isatin hybrids: synthesis, biological assessment, and computational modeling.

Discovery of novel anti-Toxoplasma gondii agent derived from thiazolidinone-isatin hybrids: synthesis, biological assessment, and computational modeling.

Journal: RSC advances

Published: May 28, 2026

Identification of Quinoline Tethered Thiadiazole/Thiazole Derivatives as Potent Tyrosinase Inhibitors With Promising Anti-Toxoplasma gondii Agents: Design, Synthesis, and Computational Analysis.

Identification of Quinoline Tethered Thiadiazole/Thiazole Derivatives as Potent Tyrosinase Inhibitors With Promising Anti-Toxoplasma gondii Agents: Design, Synthesis, and Computational Analysis.

Journal: Drug development research

Published: April 11, 2026

Recombinant ROP8 antigen: diagnostics, immunogenicity, and therapeutic targeting in toxoplasmosis.

Recombinant ROP8 antigen: diagnostics, immunogenicity, and therapeutic targeting in toxoplasmosis.

Journal: Frontiers in immunology

Published: December 16, 2025

The Trivalent Recombinant Chimeric Proteins Containing Immunodominant Fragments of Toxoplasma gondii SAG1 and SAG2 Antigens in Their Core-A Good Diagnostic Tool for Detecting IgG Antibodies in Human Serum Samples.

The Trivalent Recombinant Chimeric Proteins Containing Immunodominant Fragments of Toxoplasma gondii SAG1 and SAG2 Antigens in Their Core-A Good Diagnostic Tool for Detecting IgG Antibodies in Human Serum Samples.

Journal: International journal of molecular sciences

Published: May 07, 2025

Identification of Coumarin-Chalcone and Coumarin-Pyrazoline Derivatives as Novel Anti-Toxoplasma gondii Agents.

Identification of Coumarin-Chalcone and Coumarin-Pyrazoline Derivatives as Novel Anti-Toxoplasma gondii Agents.

Journal: Drug design, development and therapy

Published: October 04, 2024

Immunogenicity and protective efficacy of recombinant chimeric antigens based on surface proteins of Toxoplasma gondii.

Immunogenicity and protective efficacy of recombinant chimeric antigens based on surface proteins of Toxoplasma gondii.

Journal: Frontiers in immunology

Published: August 13, 2024

The Development of Toxoplasma gondii Recombinant Trivalent Chimeric Proteins as an Alternative to Toxoplasma Lysate Antigen (TLA) in Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Immunoglobulin G (IgG) in Small Ruminants.

The Development of Toxoplasma gondii Recombinant Trivalent Chimeric Proteins as an Alternative to Toxoplasma Lysate Antigen (TLA) in Enzyme-Linked Immunosorbent Assay (ELISA) for the Detection of Immunoglobulin G (IgG) in Small Ruminants.

Journal: International journal of molecular sciences

Published: February 28, 2024

Effect of sodium L-lactate on bioactive properties of chitosan-hydroxyapatite/polycaprolactone conduits for peripheral nerve tissue engineering.

Effect of sodium L-lactate on bioactive properties of chitosan-hydroxyapatite/polycaprolactone conduits for peripheral nerve tissue engineering.

Journal: International journal of biological macromolecules

Published: February 22, 2024

Diminishing of Helicobacter pylori adhesion to Cavia porcellus gastric epithelial cells by BCG vaccine mycobacteria.

Diminishing of Helicobacter pylori adhesion to Cavia porcellus gastric epithelial cells by BCG vaccine mycobacteria.

Journal: Scientific reports

Published: June 21, 2023

Evaluation of long-term immunity and protection against T. gondii after immunization with multivalent recombinant chimeric T. gondii proteins.

Evaluation of long-term immunity and protection against T. gondii after immunization with multivalent recombinant chimeric T. gondii proteins.

Journal: Scientific reports

Published: March 07, 2023

Mycobacterium bovis BCG increase the selected determinants of monocyte/macrophage activity, which were diminished in response to gastric pathogen Helicobacter pylori.

Mycobacterium bovis BCG increase the selected determinants of monocyte/macrophage activity, which were diminished in response to gastric pathogen Helicobacter pylori.

Journal: Scientific reports

Published: November 11, 2022

4-Arylthiosemicarbazide derivatives - Pharmacokinetics, toxicity and anti-Toxoplasma gondii activity in vivo.

4-Arylthiosemicarbazide derivatives - Pharmacokinetics, toxicity and anti-Toxoplasma gondii activity in vivo.

Journal: European journal of medicinal chemistry

Published: April 12, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026